23andMe CEO Anne Wojcicki Says She’s Weighing Buyout Bid
The executive has voting control of about 49% over the the DNA testing company
In the fiscal third quarter, ended in December, 23andMe had revenue of $44.7 million, down 33% from a year earlier. For the first nine months of its fiscal year, the company had revenue of $155.6 million, down 25%.
In a filing with the Securities and Exchange Commission, 23andMe said it has enough cash on hand to support operations for at least one year. The company last year said Nasdaq had warned it that it was no longer in compliance with a requirement to maintain a bid price of at least $1 a share, and could be subject to delisting.
Компания убыточна, выручка и прибыль падают, денег осталось на год, Анна попробует выкупить